Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

SOTAC PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.8917.632.661.5112.26

What is the latest EV/Core EBITDA ratio of SOTAC PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SOTAC PHARMACEUTICALS is 9.89 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20259.89
Mar202417.63
Mar20232.66
Mar20221.51
Mar202112.26

How is EV/Core EBITDA of SOTAC PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 9.89
-43.90
Mar2024 17.63
562.78
Mar2023 2.66
76.16
Mar2022 1.51
-87.68
Mar2021 12.26 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹113.2 Cr -11.3% -9% -18.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -2.2% -1.8% -2.4% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -1.6% -7.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -4.1% -6.7% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -4.7% -7.3% 6.4% Stock Analytics
CIPLA ₹97,115.7 Cr -1.7% -8.4% -16.7% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-11.3%

-9%

-18.5%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses